May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
The Effects of Pupil Dilation on Intraocular Pressure and Ocular Pulse Amplitude in Patients With Age-Related Macular Degeneration
Author Affiliations & Notes
  • E. Rechtman
    Goldschleger Eye Institute, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel
  • A. Harris
    Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana
  • A. Leys
    Ophthalmology, University Hospitals Leuven, Leuven, Belgium
  • J. Moisseiev
    Goldschleger Eye Institute, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel
  • J. Van Calster
    Ophthalmology, University Hospitals Leuven, Leuven, Belgium
  • J. Glovinsky
    Goldschleger Eye Institute, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel
  • I. Stalmans
    Ophthalmology, University Hospitals Leuven, Leuven, Belgium
  • Footnotes
    Commercial Relationships  E. Rechtman, None; A. Harris, None; A. Leys, None; J. Moisseiev, None; J. Van Calster, None; J. Glovinsky, None; I. Stalmans, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 2104. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E. Rechtman, A. Harris, A. Leys, J. Moisseiev, J. Van Calster, J. Glovinsky, I. Stalmans; The Effects of Pupil Dilation on Intraocular Pressure and Ocular Pulse Amplitude in Patients With Age-Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2104.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To assess the effects of pupil dilation on intraocular and ocular pulse pressures (IOP & OPA, respectively) in eyes with age-related macular degeneration (AMD).

Methods: : This assessment is part of a bi-center prospective study (Sheba Medical Center, Israel and University Hospitals Leuven, Belgium), evaluating the effect of intravitreal bevacizumab treatment on IOP/OPA. After signing an informed consent, all patients have been examined 3 times: At days 0 (prior to injection), 7(± 3) and 30 (± 7) post injection. At each visit, pre and post pupil dilation (tropicamide 1% ± phenylephrine 10%) IOP/OPA of both eyes were measured, using the Dynamic Contour Tonometer (DCT, Pascal; Swiss Microthecnology AG, Prt, Switzerland). Each time, up to 3 DCT measurements were performed to reach a test with good quality (quality 1-2 out of 5, best tests taken for calculation). Paired t test between pre and post pupil dilation IOP/OPA was preformed in all exams.

Results: : Thirty five neovascular AMD patients (21 females, age 79 ± 5.9 years (mean ±SD)) were recruited. Mean±SD axial length was 23.37±0.96mm (study eye) and 23.44±1.13mm (fellow eye), while mean±SD central corneal thickness was 550.8±38.2µm (study eye) and 549.5±40.8µm (fellow eye). A total of 746 DCT measurements were performed and final mean DCT test quality was 2. Pre and post pupil dilation IOP/OPA (mean±SD) were 15.3±2.9mmHg/2.3±1mmHg versus 15.5±3.3mmHg/2.5±1mmHg in the study eye, and 15.8±3.4mmHg/2.5±0.9mmHg versus 16.2±3.5mmHg/2.5±1mmHg in the fellow eye. There were no statistically significant differences between any of the parameters pre and post pupil dilation.

Conclusions: : Overall, in this elderly population with neovascular AMD, nor IOP neither OPA (a results of IOP fluctuations according to the cardiac cycle and which mostly comes from the choroidal circulation) were significantly altered by pupil dilation.

Clinical Trial: : 4739/07

Keywords: intraocular pressure • choroid 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×